Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313238071> ?p ?o ?g. }
- W4313238071 endingPage "112" @default.
- W4313238071 startingPage "112" @default.
- W4313238071 abstract "Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with a high risk of metastasis and therapeutic resistance. These issues are closely linked to the tumour microenvironment (TME) surrounding the tumour tissue. The association between residing TME components with tumour progression, survival, and metastasis has been well elucidated. Focusing on cancer cells alone is no longer considered a viable approach to therapy; thus, there is a high demand for TME targeting. The benefit of using nanoparticles is their preferential tumour accumulation and their ability to target TME components. Several nano-based platforms have been investigated to mitigate microenvironment-induced angiogenesis, therapeutic resistance, and tumour progression. These have been achieved by targeting mesenchymal originating cells (e.g., cancer-associated fibroblasts, adipocytes, and stem cells), haematological cells (e.g., tumour-associated macrophages, dendritic cells, and myeloid-derived suppressor cells), and the extracellular matrix within the TME that displays functional and architectural support. This review highlights the importance of nanotechnology-based therapeutics as a promising approach to target the TME and improve treatment outcomes for TNBC patients, which can lead to enhanced survival and quality of life. The role of different nanotherapeutics has been explored in the established TME cell-driven populations." @default.
- W4313238071 created "2023-01-06" @default.
- W4313238071 creator A5008262727 @default.
- W4313238071 creator A5033619787 @default.
- W4313238071 creator A5057283061 @default.
- W4313238071 date "2022-12-29" @default.
- W4313238071 modified "2023-09-25" @default.
- W4313238071 title "Potential Nanotechnology-Based Therapeutics to Prevent Cancer Progression through TME Cell-Driven Populations" @default.
- W4313238071 cites W1800064620 @default.
- W4313238071 cites W2020092749 @default.
- W4313238071 cites W2039004541 @default.
- W4313238071 cites W2046889690 @default.
- W4313238071 cites W2055085590 @default.
- W4313238071 cites W2057320783 @default.
- W4313238071 cites W2075485140 @default.
- W4313238071 cites W2079641266 @default.
- W4313238071 cites W2117035099 @default.
- W4313238071 cites W2158431756 @default.
- W4313238071 cites W2161083472 @default.
- W4313238071 cites W2222000147 @default.
- W4313238071 cites W2323501321 @default.
- W4313238071 cites W2338768170 @default.
- W4313238071 cites W2409318264 @default.
- W4313238071 cites W2417235409 @default.
- W4313238071 cites W2435243879 @default.
- W4313238071 cites W2460584341 @default.
- W4313238071 cites W2493010869 @default.
- W4313238071 cites W2555883270 @default.
- W4313238071 cites W2562579911 @default.
- W4313238071 cites W2565723682 @default.
- W4313238071 cites W2607351395 @default.
- W4313238071 cites W2744578405 @default.
- W4313238071 cites W2754823840 @default.
- W4313238071 cites W2759978833 @default.
- W4313238071 cites W2767025366 @default.
- W4313238071 cites W2797429263 @default.
- W4313238071 cites W2890059688 @default.
- W4313238071 cites W2901307735 @default.
- W4313238071 cites W2902626376 @default.
- W4313238071 cites W2902757945 @default.
- W4313238071 cites W2907564726 @default.
- W4313238071 cites W2919326530 @default.
- W4313238071 cites W2921727504 @default.
- W4313238071 cites W2923394609 @default.
- W4313238071 cites W2966710588 @default.
- W4313238071 cites W2969545909 @default.
- W4313238071 cites W2970704945 @default.
- W4313238071 cites W2975369641 @default.
- W4313238071 cites W2985479685 @default.
- W4313238071 cites W2999063177 @default.
- W4313238071 cites W3003951026 @default.
- W4313238071 cites W3007644502 @default.
- W4313238071 cites W3014006805 @default.
- W4313238071 cites W3015456794 @default.
- W4313238071 cites W3022610090 @default.
- W4313238071 cites W3029938788 @default.
- W4313238071 cites W3033869790 @default.
- W4313238071 cites W3046626762 @default.
- W4313238071 cites W3047597874 @default.
- W4313238071 cites W3069503050 @default.
- W4313238071 cites W3086886431 @default.
- W4313238071 cites W3087683890 @default.
- W4313238071 cites W3090606514 @default.
- W4313238071 cites W3095000040 @default.
- W4313238071 cites W3096284040 @default.
- W4313238071 cites W3106755160 @default.
- W4313238071 cites W3108853735 @default.
- W4313238071 cites W3113938755 @default.
- W4313238071 cites W3119150889 @default.
- W4313238071 cites W3122794709 @default.
- W4313238071 cites W3127703512 @default.
- W4313238071 cites W3130164176 @default.
- W4313238071 cites W3134387579 @default.
- W4313238071 cites W3158494824 @default.
- W4313238071 cites W3168119119 @default.
- W4313238071 cites W3189475625 @default.
- W4313238071 cites W3212705361 @default.
- W4313238071 cites W4210297691 @default.
- W4313238071 cites W4223647938 @default.
- W4313238071 doi "https://doi.org/10.3390/pharmaceutics15010112" @default.
- W4313238071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36678741" @default.
- W4313238071 hasPublicationYear "2022" @default.
- W4313238071 type Work @default.
- W4313238071 citedByCount "1" @default.
- W4313238071 countsByYear W43132380712023 @default.
- W4313238071 crossrefType "journal-article" @default.
- W4313238071 hasAuthorship W4313238071A5008262727 @default.
- W4313238071 hasAuthorship W4313238071A5033619787 @default.
- W4313238071 hasAuthorship W4313238071A5057283061 @default.
- W4313238071 hasBestOaLocation W43132380711 @default.
- W4313238071 hasConcept C121608353 @default.
- W4313238071 hasConcept C126322002 @default.
- W4313238071 hasConcept C142724271 @default.
- W4313238071 hasConcept C16930146 @default.
- W4313238071 hasConcept C198826908 @default.
- W4313238071 hasConcept C2776107976 @default.
- W4313238071 hasConcept C2779013556 @default.
- W4313238071 hasConcept C2780394083 @default.